How is the severity of aortic stenosis graded by echocardiography (echo) in patients with suspected aortic stenosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Aortic Stenosis Severity Grading by Echocardiography

Aortic stenosis severity is graded by integrating three primary echocardiographic parameters: peak aortic jet velocity, mean transvalvular gradient, and aortic valve area calculated by the continuity equation, with severe AS defined as velocity ≥4 m/s, mean gradient ≥40 mmHg, and valve area ≤1.0 cm². 1

Primary Severity Parameters

The classification system uses the following thresholds 1:

Severe AS:

  • Peak aortic jet velocity ≥4.0 m/s
  • Mean pressure gradient ≥40 mmHg
  • Aortic valve area (AVA) ≤1.0 cm²
  • Indexed AVA ≤0.6 cm²/m²

Moderate AS:

  • Peak velocity 3.0-3.9 m/s
  • Mean gradient 20-39 mmHg
  • AVA 1.0-1.5 cm²

Mild AS:

  • Peak velocity 2.5-2.9 m/s
  • Mean gradient <20 mmHg
  • AVA >1.5 cm²

Critical Measurement Technique

LVOT diameter measurement is the single largest source of error because it is squared in the continuity equation, magnifying small measurement errors 2. The LVOT should be measured at the base of the aortic valve cusps or 1-5 mm below 1.

Peak velocity must be obtained from multiple acoustic windows (apical, right parasternal, suprasternal, subcostal) to capture the highest velocity signal and avoid underestimation from beam misalignment 2, 1.

Algorithmic Approach Based on Gradient

High Gradient AS (Mean Gradient ≥40 mmHg)

This represents the straightforward scenario 1:

  • High gradient generally confirms severe AS regardless of flow state 1
  • No additional testing needed to confirm severity 1
  • The only exception is abnormally high flow states (stroke volume index >58 mL/m²) from conditions like anemia, hyperthyroidism, or arteriovenous shunts, which should be corrected before reassessment 1

Low Gradient AS (Mean Gradient <40 mmHg)

This is the "difficult track" requiring extensive evaluation 1:

Step 1: Calculate AVA

  • If AVA >1.0 cm², this indicates moderate AS 1
  • If AVA <1.0 cm², proceed to flow assessment 1

Step 2: Determine Flow Status

  • Normal flow: Stroke volume index ≥35 mL/m² 1
  • Low flow: Stroke volume index <35 mL/m² 1

Step 3: Flow-Based Classification

Normal Flow, Low Gradient (AVA <1.0 cm²):

  • Severe AS is very unlikely despite calculated AVA <1.0 cm² 1
  • Most likely represents moderate AS with measurement error 1
  • Carefully recheck LVOT measurement for underestimation 1, 2

Low Flow, Low Gradient with Reduced EF (<50%):

  • Perform dobutamine stress echocardiography (≤20 μg/kg/min) 1
  • True severe AS: Mean gradient ≥40 mmHg AND AVA ≤1.0 cm² at any dobutamine stage 1
  • Pseudosevere AS: AVA increases >0.3 cm² or to >1.2 cm² with gradient remaining <40 mmHg 1
  • If no contractile reserve (stroke volume increase <20%), use **CT calcium scoring**: severe AS confirmed by >2000 Agatston units (men) or >1300 units (women) 1

Low Flow, Low Gradient with Preserved EF (≥50%)—"Paradoxical Low Flow":

  • This represents a particularly challenging subset 1
  • Consider 3D echocardiography to verify stroke volume and AVA measurements 1
  • CT calcium scoring is highly valuable: >1200 Agatston units (women) or >2000 units (men) confirms severe AS 1
  • Dobutamine stress echo may help distinguish true from pseudosevere AS 1

Common Pitfalls and How to Avoid Them

LVOT Area Underestimation:

  • The LVOT is elliptical, not circular 2
  • Using only the sagittal diameter systematically underestimates LVOT area, leading to underestimation of stroke volume and AVA 1
  • Consider 3D transesophageal echo or CT for direct LVOT planimetry 1, 2

Hypertension Effects:

  • Elevated blood pressure can alter velocity and gradient measurements 2
  • Record blood pressure during examination 1
  • If blood pressure and valvulo-arterial impedance (Zva) are elevated (>4.5-5 mmHg/m²), optimize antihypertensive therapy and repeat echo after normalization 1

Discordant Parameters:

  • When AVA <1.0 cm² but velocity <4 m/s and gradient <40 mmHg, this is the most challenging scenario 2
  • Never rely on a single parameter in isolation 2
  • Systematically exclude measurement errors for all components 1, 2

Integration with Additional Parameters

Beyond the primary grading parameters, assess 1:

  • Valve morphology: Tricuspid vs bicuspid, degree of calcification
  • LV function and geometry: Ejection fraction, wall thickness, chamber dimensions
  • Hemodynamic consequences: Left atrial size, pulmonary pressures
  • Symptom status: Critical for clinical decision-making

Clinically significant progression is defined as mean gradient increase >10 mmHg or AVA decrease >25% from baseline 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Echocardiographic Assessment of Aortic Stenosis Uncertainty

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the diagnosis for an aortic valve with normal structure, peak velocity of 1.7 meters per second (m/s), left ventricular outflow tract (LVOT) peak velocity of 1.1 m/s, no stenosis, peak gradient of 11 millimeters of mercury (mmHg), no regurgitation, mean gradient of 5 mmHg, area of 2.4 square centimeters (cm²), and diameter of 2.1 centimeters (cm)?
What is Gallavardin's phenomenon, also known as Gallavardin (Gallavardin) phenomenon?
What are the diagnostic criteria for aortic stenosis (Aortic Valve Stenosis)?
What are the echocardiographic criteria for diagnosing aortic stenosis?
What is the recommended monitoring and management for a patient with aortic sclerosis without regurgitation or stenosis?
What is the best course of action for a patient with a history of stroke, currently experiencing dizziness and a heated face, while being treated with clonidine (antihypertensive) for elevated blood pressure?
What is the appropriate management and treatment approach for a patient with community-acquired pneumonia (CAP), considering their age, underlying health conditions, smoking status, recent travel or exposure history, and previous episodes of pneumonia?
What are the treatment options for a patient with laryngopharyngeal reflux?
What is the best time to administer a Proton Pump Inhibitor (PPI) to a patient with Gastroesophageal Reflux Disease (GERD) or peptic ulcer disease?
When is a calcium CT score used to determine the true severity of aortic stenosis (AS) in patients with low-flow, low-gradient AS and preserved left ventricular ejection fraction (LVEF)?
What are the benefits and risks of using Milk Kefir for digestive health and immune system support in a generally healthy individual with potential dairy allergies or intolerances?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.